| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Herpesvirus 1, Human | 120 | 2020 | 244 | 25.800 |
Why?
|
| Viral Proteins | 69 | 2020 | 300 | 12.740 |
Why?
|
| Immediate-Early Proteins | 55 | 2018 | 164 | 11.690 |
Why?
|
| Virus Replication | 48 | 2020 | 319 | 6.970 |
Why?
|
| Gene Expression Regulation, Viral | 31 | 2018 | 90 | 6.590 |
Why?
|
| Ubiquitin-Protein Ligases | 33 | 2016 | 165 | 6.560 |
Why?
|
| Simplexvirus | 22 | 2017 | 151 | 5.700 |
Why?
|
| Herpes Simplex | 29 | 2020 | 202 | 5.310 |
Why?
|
| RNA, Messenger | 26 | 2020 | 1988 | 3.760 |
Why?
|
| Ribonucleases | 13 | 2015 | 92 | 3.520 |
Why?
|
| Virus Latency | 9 | 2015 | 33 | 3.500 |
Why?
|
| Apoptosis | 24 | 2014 | 1689 | 3.130 |
Why?
|
| Viral Envelope Proteins | 14 | 2010 | 95 | 2.660 |
Why?
|
| Cell Line | 56 | 2016 | 2476 | 2.600 |
Why?
|
| Virion | 13 | 2015 | 59 | 2.400 |
Why?
|
| RNA, Viral | 15 | 2014 | 330 | 2.380 |
Why?
|
| Cell Nucleus | 15 | 2013 | 581 | 2.360 |
Why?
|
| Host-Pathogen Interactions | 10 | 2015 | 232 | 2.360 |
Why?
|
| Repressor Proteins | 10 | 2013 | 405 | 2.240 |
Why?
|
| Nuclear Proteins | 16 | 2019 | 705 | 2.070 |
Why?
|
| Vero Cells | 29 | 2020 | 101 | 2.070 |
Why?
|
| Virus Activation | 6 | 2014 | 41 | 2.040 |
Why?
|
| Cytoplasm | 15 | 2013 | 282 | 1.860 |
Why?
|
| MicroRNAs | 8 | 2020 | 535 | 1.810 |
Why?
|
| DNA-Binding Proteins | 15 | 2010 | 1214 | 1.700 |
Why?
|
| Genes, Viral | 17 | 2013 | 116 | 1.660 |
Why?
|
| Animals | 94 | 2020 | 26706 | 1.530 |
Why?
|
| Histone Deacetylase Inhibitors | 5 | 2010 | 85 | 1.510 |
Why?
|
| Virus Assembly | 7 | 2017 | 21 | 1.490 |
Why?
|
| CDC2 Protein Kinase | 7 | 2008 | 45 | 1.470 |
Why?
|
| Protein Kinases | 10 | 2014 | 209 | 1.460 |
Why?
|
| Promyelocytic Leukemia Protein | 6 | 2017 | 8 | 1.420 |
Why?
|
| Ganglia | 3 | 2015 | 14 | 1.410 |
Why?
|
| Nerve Tissue Proteins | 5 | 2013 | 504 | 1.410 |
Why?
|
| DNA, Viral | 13 | 2013 | 265 | 1.350 |
Why?
|
| Transcription Factors | 10 | 2011 | 1580 | 1.230 |
Why?
|
| Humans | 135 | 2020 | 86656 | 1.190 |
Why?
|
| Protein Processing, Post-Translational | 13 | 2011 | 371 | 1.190 |
Why?
|
| HeLa Cells | 20 | 2012 | 498 | 1.190 |
Why?
|
| Interferon-gamma | 6 | 2019 | 445 | 1.170 |
Why?
|
| RNA-Binding Proteins | 6 | 2017 | 251 | 1.140 |
Why?
|
| Membrane Proteins | 9 | 2019 | 1201 | 1.130 |
Why?
|
| Mutation | 33 | 2014 | 3977 | 1.120 |
Why?
|
| Histone Deacetylases | 9 | 2019 | 65 | 1.080 |
Why?
|
| eIF-2 Kinase | 6 | 2013 | 46 | 1.070 |
Why?
|
| Viral Regulatory and Accessory Proteins | 9 | 2008 | 23 | 1.050 |
Why?
|
| Genome, Viral | 8 | 2010 | 74 | 1.040 |
Why?
|
| RNA Stability | 8 | 2013 | 86 | 1.030 |
Why?
|
| Genetic Therapy | 11 | 2006 | 343 | 1.000 |
Why?
|
| Fibroblasts | 9 | 2014 | 731 | 1.000 |
Why?
|
| Antigens, Nuclear | 3 | 2017 | 25 | 0.970 |
Why?
|
| Rabbits | 21 | 2010 | 638 | 0.960 |
Why?
|
| Apoptosis Regulatory Proteins | 6 | 2015 | 199 | 0.930 |
Why?
|
| Viral Fusion Proteins | 2 | 2013 | 10 | 0.930 |
Why?
|
| Genetic Vectors | 11 | 2018 | 440 | 0.910 |
Why?
|
| Autoantigens | 3 | 2017 | 127 | 0.910 |
Why?
|
| Phosphorylation | 18 | 2008 | 1106 | 0.900 |
Why?
|
| Cell Nucleus Structures | 3 | 2017 | 3 | 0.880 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 4 | 2003 | 17 | 0.860 |
Why?
|
| Endoribonucleases | 3 | 2009 | 92 | 0.850 |
Why?
|
| Ligases | 4 | 2003 | 45 | 0.840 |
Why?
|
| Cyclins | 4 | 2009 | 82 | 0.840 |
Why?
|
| Caspase Inhibitors | 4 | 2007 | 33 | 0.790 |
Why?
|
| CLOCK Proteins | 2 | 2011 | 15 | 0.790 |
Why?
|
| Trigeminal Ganglion | 4 | 2014 | 16 | 0.770 |
Why?
|
| Receptors, Interleukin | 3 | 2006 | 35 | 0.760 |
Why?
|
| Antiviral Agents | 4 | 2019 | 512 | 0.750 |
Why?
|
| Neoplasm Proteins | 5 | 2004 | 532 | 0.740 |
Why?
|
| Plasmids | 5 | 2015 | 292 | 0.730 |
Why?
|
| Transfection | 14 | 2013 | 898 | 0.730 |
Why?
|
| Tristetraprolin | 4 | 2015 | 6 | 0.720 |
Why?
|
| HEK293 Cells | 7 | 2020 | 617 | 0.710 |
Why?
|
| DNA Primers | 9 | 2015 | 545 | 0.710 |
Why?
|
| Recombinant Fusion Proteins | 11 | 2015 | 560 | 0.690 |
Why?
|
| Mice | 31 | 2016 | 11439 | 0.690 |
Why?
|
| Glioma | 6 | 2011 | 285 | 0.670 |
Why?
|
| Open Reading Frames | 7 | 2010 | 117 | 0.660 |
Why?
|
| Base Sequence | 11 | 2015 | 2335 | 0.650 |
Why?
|
| Protein Structure, Tertiary | 7 | 2009 | 738 | 0.650 |
Why?
|
| Molecular Sequence Data | 12 | 2015 | 3035 | 0.650 |
Why?
|
| Enzyme Activation | 14 | 2009 | 693 | 0.640 |
Why?
|
| cdc25 Phosphatases | 2 | 2008 | 18 | 0.640 |
Why?
|
| Transcription, Genetic | 9 | 2011 | 1138 | 0.630 |
Why?
|
| Cells, Cultured | 14 | 2018 | 2839 | 0.620 |
Why?
|
| Caspases | 7 | 2009 | 155 | 0.620 |
Why?
|
| RNA Interference | 4 | 2018 | 370 | 0.610 |
Why?
|
| 3' Untranslated Regions | 6 | 2015 | 92 | 0.600 |
Why?
|
| Immunoblotting | 7 | 2015 | 268 | 0.600 |
Why?
|
| Cyclin-Dependent Kinase 9 | 2 | 2008 | 6 | 0.600 |
Why?
|
| Co-Repressor Proteins | 6 | 2016 | 18 | 0.590 |
Why?
|
| Oncolytic Virotherapy | 5 | 2011 | 41 | 0.590 |
Why?
|
| Cell Line, Tumor | 15 | 2017 | 2427 | 0.580 |
Why?
|
| Science | 2 | 2020 | 34 | 0.570 |
Why?
|
| Cyclin D3 | 4 | 2010 | 20 | 0.570 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2016 | 3 | 0.570 |
Why?
|
| Protein Binding | 11 | 2011 | 1462 | 0.560 |
Why?
|
| Exosomes | 3 | 2020 | 50 | 0.560 |
Why?
|
| Laboratory Personnel | 1 | 2015 | 2 | 0.550 |
Why?
|
| Virology | 1 | 2015 | 9 | 0.550 |
Why?
|
| Activating Transcription Factor 3 | 1 | 2015 | 5 | 0.540 |
Why?
|
| Viral Structural Proteins | 2 | 2007 | 19 | 0.520 |
Why?
|
| MAP Kinase Kinase Kinases | 2 | 2013 | 41 | 0.520 |
Why?
|
| Gene Deletion | 9 | 2013 | 337 | 0.480 |
Why?
|
| Dexamethasone | 2 | 2013 | 326 | 0.480 |
Why?
|
| Carrier Proteins | 3 | 2003 | 675 | 0.470 |
Why?
|
| NF-kappa B | 4 | 2004 | 447 | 0.470 |
Why?
|
| Nuclear Envelope | 2 | 2006 | 36 | 0.470 |
Why?
|
| Ubiquitin | 3 | 2003 | 93 | 0.470 |
Why?
|
| RNA | 4 | 2006 | 561 | 0.470 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2010 | 28 | 0.460 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2013 | 18 | 0.460 |
Why?
|
| Models, Biological | 11 | 2014 | 1752 | 0.450 |
Why?
|
| Macromolecular Substances | 1 | 2013 | 177 | 0.450 |
Why?
|
| STAT3 Transcription Factor | 1 | 2013 | 78 | 0.450 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 5 | 2003 | 30 | 0.450 |
Why?
|
| Up-Regulation | 6 | 2008 | 717 | 0.450 |
Why?
|
| Biotinylation | 1 | 2012 | 41 | 0.440 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2007 | 189 | 0.440 |
Why?
|
| Immune Evasion | 1 | 2013 | 33 | 0.440 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2008 | 279 | 0.430 |
Why?
|
| Brain Neoplasms | 5 | 2014 | 763 | 0.430 |
Why?
|
| Protein Transport | 6 | 2013 | 411 | 0.430 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2012 | 63 | 0.420 |
Why?
|
| Virulence Factors | 1 | 2013 | 110 | 0.420 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2006 | 645 | 0.410 |
Why?
|
| Interferons | 3 | 2012 | 133 | 0.410 |
Why?
|
| DNA, Complementary | 4 | 2012 | 394 | 0.410 |
Why?
|
| Ganglia, Spinal | 1 | 2011 | 72 | 0.410 |
Why?
|
| Multienzyme Complexes | 5 | 2002 | 64 | 0.410 |
Why?
|
| Immunoprecipitation | 5 | 2014 | 135 | 0.400 |
Why?
|
| Cysteine Endopeptidases | 5 | 2002 | 87 | 0.400 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 2065 | 0.400 |
Why?
|
| Caspase 3 | 7 | 2007 | 159 | 0.390 |
Why?
|
| Transcriptional Activation | 2 | 2010 | 282 | 0.390 |
Why?
|
| Laryngeal Neoplasms | 3 | 2019 | 89 | 0.390 |
Why?
|
| Virus Integration | 1 | 2010 | 16 | 0.380 |
Why?
|
| Baculoviridae | 7 | 2006 | 34 | 0.380 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2011 | 102 | 0.380 |
Why?
|
| Immunity, Innate | 3 | 2019 | 410 | 0.370 |
Why?
|
| Multiprotein Complexes | 3 | 2005 | 95 | 0.370 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2010 | 70 | 0.370 |
Why?
|
| Capsid Proteins | 4 | 2008 | 32 | 0.370 |
Why?
|
| Cyclin D1 | 3 | 2009 | 83 | 0.370 |
Why?
|
| Histone Deacetylase 1 | 5 | 2009 | 13 | 0.360 |
Why?
|
| Amino Acid Substitution | 6 | 2015 | 339 | 0.360 |
Why?
|
| Gene Silencing | 2 | 2007 | 173 | 0.360 |
Why?
|
| Virulence | 5 | 2014 | 274 | 0.350 |
Why?
|
| Polyribosomes | 1 | 2009 | 20 | 0.350 |
Why?
|
| Transduction, Genetic | 6 | 2007 | 153 | 0.350 |
Why?
|
| Binding Sites | 7 | 2007 | 1104 | 0.350 |
Why?
|
| Glutathione Transferase | 6 | 2006 | 111 | 0.350 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2016 | 306 | 0.350 |
Why?
|
| Neoplasms | 7 | 2012 | 2898 | 0.340 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2015 | 280 | 0.340 |
Why?
|
| Oxidoreductases, N-Demethylating | 1 | 2009 | 14 | 0.340 |
Why?
|
| Exons | 4 | 2005 | 452 | 0.340 |
Why?
|
| RNA Polymerase II | 2 | 2008 | 55 | 0.340 |
Why?
|
| Hyperplasia | 4 | 2007 | 148 | 0.340 |
Why?
|
| Receptors, Virus | 3 | 2005 | 75 | 0.340 |
Why?
|
| Proteins | 2 | 2004 | 777 | 0.340 |
Why?
|
| Tumor Cells, Cultured | 11 | 2018 | 1041 | 0.330 |
Why?
|
| Microscopy, Confocal | 4 | 2012 | 268 | 0.330 |
Why?
|
| Mice, Inbred CBA | 4 | 2013 | 52 | 0.330 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 2 | 2007 | 5 | 0.330 |
Why?
|
| Capsid | 4 | 2007 | 34 | 0.320 |
Why?
|
| Skin | 4 | 2005 | 554 | 0.320 |
Why?
|
| Enzyme Inhibitors | 3 | 2008 | 639 | 0.320 |
Why?
|
| Gene Expression Regulation | 6 | 2018 | 1928 | 0.310 |
Why?
|
| Microscopy, Fluorescence | 4 | 2012 | 425 | 0.310 |
Why?
|
| Trans-Activators | 3 | 2005 | 430 | 0.310 |
Why?
|
| RNA Helicases | 3 | 2019 | 35 | 0.310 |
Why?
|
| Neurons | 3 | 2013 | 1547 | 0.310 |
Why?
|
| Sequence Deletion | 4 | 2013 | 206 | 0.300 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2006 | 108 | 0.300 |
Why?
|
| Radiation, Ionizing | 4 | 2014 | 121 | 0.300 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2007 | 17 | 0.300 |
Why?
|
| Cell Cycle Proteins | 2 | 2019 | 388 | 0.290 |
Why?
|
| DNA | 3 | 2008 | 1295 | 0.290 |
Why?
|
| Angioplasty, Balloon | 1 | 2007 | 95 | 0.290 |
Why?
|
| Recombinant Proteins | 6 | 2013 | 1018 | 0.290 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2006 | 24 | 0.290 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2006 | 43 | 0.280 |
Why?
|
| Cell Communication | 2 | 2019 | 195 | 0.280 |
Why?
|
| Viral Vaccines | 2 | 2006 | 44 | 0.280 |
Why?
|
| Spodoptera | 5 | 2004 | 32 | 0.280 |
Why?
|
| Leupeptins | 5 | 2006 | 21 | 0.280 |
Why?
|
| Membrane Fusion | 1 | 2006 | 37 | 0.280 |
Why?
|
| src-Family Kinases | 1 | 2006 | 75 | 0.270 |
Why?
|
| Herpesvirus 4, Human | 1 | 2006 | 114 | 0.270 |
Why?
|
| STAT1 Transcription Factor | 5 | 2012 | 52 | 0.260 |
Why?
|
| Interleukin-13 | 1 | 2005 | 36 | 0.260 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 881 | 0.260 |
Why?
|
| Radiation Tolerance | 4 | 2012 | 168 | 0.250 |
Why?
|
| Gene Expression | 7 | 2010 | 1286 | 0.250 |
Why?
|
| Genes, Reporter | 4 | 2007 | 271 | 0.250 |
Why?
|
| Proteasome Endopeptidase Complex | 5 | 2002 | 100 | 0.250 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 323 | 0.250 |
Why?
|
| AU Rich Elements | 2 | 2015 | 3 | 0.250 |
Why?
|
| Recombination, Genetic | 5 | 2006 | 439 | 0.240 |
Why?
|
| Genetic Engineering | 5 | 2007 | 115 | 0.240 |
Why?
|
| Viruses | 1 | 2004 | 78 | 0.240 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2012 | 318 | 0.240 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 1387 | 0.240 |
Why?
|
| Cytochrome c Group | 2 | 2000 | 82 | 0.230 |
Why?
|
| Interferon-alpha | 2 | 2007 | 234 | 0.230 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2004 | 105 | 0.230 |
Why?
|
| Iron-Binding Proteins | 1 | 2003 | 15 | 0.230 |
Why?
|
| Herpesvirus 2, Human | 2 | 2002 | 45 | 0.230 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2003 | 20 | 0.230 |
Why?
|
| Cell Fusion | 1 | 2003 | 39 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2014 | 62 | 0.220 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2005 | 159 | 0.220 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 4 | 2003 | 16 | 0.220 |
Why?
|
| Kinetics | 4 | 2007 | 1513 | 0.220 |
Why?
|
| Receptor, IGF Type 2 | 1 | 2002 | 6 | 0.220 |
Why?
|
| Biological Transport | 3 | 2014 | 396 | 0.210 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 164 | 0.210 |
Why?
|
| Calcium | 1 | 2007 | 1156 | 0.210 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2002 | 16 | 0.210 |
Why?
|
| ErbB Receptors | 1 | 2005 | 486 | 0.210 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2001 | 25 | 0.210 |
Why?
|
| Exodeoxyribonucleases | 1 | 2001 | 14 | 0.210 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2001 | 7 | 0.210 |
Why?
|
| Subcellular Fractions | 1 | 2001 | 94 | 0.200 |
Why?
|
| Cycloheximide | 2 | 2013 | 56 | 0.200 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 276 | 0.200 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 25 | 0.200 |
Why?
|
| Time Factors | 5 | 2011 | 5215 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2008 | 691 | 0.200 |
Why?
|
| Herpesviridae Infections | 1 | 2001 | 46 | 0.190 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 3 | 2006 | 7 | 0.190 |
Why?
|
| Receptors, Interleukin-13 | 3 | 2006 | 7 | 0.190 |
Why?
|
| Flavoproteins | 1 | 2000 | 25 | 0.190 |
Why?
|
| Exosome Multienzyme Ribonuclease Complex | 1 | 2020 | 4 | 0.190 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2020 | 4 | 0.190 |
Why?
|
| Phosphoproteins | 1 | 2002 | 255 | 0.190 |
Why?
|
| Histone Demethylases | 2 | 2011 | 30 | 0.190 |
Why?
|
| Cytomegalovirus | 1 | 2000 | 76 | 0.180 |
Why?
|
| Dyneins | 1 | 2000 | 14 | 0.180 |
Why?
|
| Cyclin B | 1 | 2000 | 17 | 0.180 |
Why?
|
| DNA Damage | 3 | 2012 | 366 | 0.180 |
Why?
|
| Cyclin A | 1 | 2000 | 28 | 0.180 |
Why?
|
| Genetic Complementation Test | 2 | 2010 | 97 | 0.180 |
Why?
|
| DNA, Neoplasm | 1 | 2001 | 265 | 0.180 |
Why?
|
| bcl-Associated Death Protein | 3 | 2006 | 16 | 0.180 |
Why?
|
| Protein Biosynthesis | 4 | 2004 | 382 | 0.180 |
Why?
|
| Sequence Analysis, DNA | 2 | 2012 | 853 | 0.170 |
Why?
|
| Information Dissemination | 1 | 2020 | 103 | 0.170 |
Why?
|
| Interferon-beta | 2 | 2017 | 125 | 0.170 |
Why?
|
| Radiotherapy | 1 | 2001 | 328 | 0.170 |
Why?
|
| History, 20th Century | 2 | 2015 | 312 | 0.170 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 269 | 0.160 |
Why?
|
| Host Cell Factor C1 | 2 | 2011 | 6 | 0.160 |
Why?
|
| Mutant Proteins | 2 | 2008 | 94 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2019 | 1077 | 0.150 |
Why?
|
| Biomarkers | 2 | 2018 | 1722 | 0.150 |
Why?
|
| Acetylation | 2 | 2008 | 121 | 0.150 |
Why?
|
| Mitochondria | 1 | 2001 | 536 | 0.150 |
Why?
|
| Signal Transduction | 4 | 2012 | 3267 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 685 | 0.150 |
Why?
|
| Histones | 2 | 2011 | 311 | 0.150 |
Why?
|
| Cyclin-Dependent Kinases | 3 | 2001 | 43 | 0.150 |
Why?
|
| ARNTL Transcription Factors | 2 | 2010 | 11 | 0.150 |
Why?
|
| Betacoronavirus | 1 | 2020 | 257 | 0.140 |
Why?
|
| Urokinase-Type Plasminogen Activator | 2 | 2007 | 47 | 0.140 |
Why?
|
| RNA, Small Interfering | 3 | 2019 | 547 | 0.140 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2010 | 75 | 0.140 |
Why?
|
| Histone Deacetylase 2 | 2 | 2006 | 6 | 0.140 |
Why?
|
| Romania | 1 | 2015 | 4 | 0.140 |
Why?
|
| Promoter Regions, Genetic | 3 | 2012 | 943 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 111 | 0.130 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 72 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 306 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 297 | 0.130 |
Why?
|
| Cell Survival | 3 | 2014 | 971 | 0.130 |
Why?
|
| Blotting, Northern | 2 | 2005 | 258 | 0.130 |
Why?
|
| T-Cell Intracellular Antigen-1 | 2 | 2004 | 6 | 0.130 |
Why?
|
| History, 21st Century | 1 | 2015 | 175 | 0.130 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 86 | 0.130 |
Why?
|
| Poly(A)-Binding Proteins | 2 | 2004 | 9 | 0.130 |
Why?
|
| Cellular Microenvironment | 1 | 2014 | 28 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 315 | 0.120 |
Why?
|
| Organ Culture Techniques | 2 | 2013 | 135 | 0.120 |
Why?
|
| Endocytosis | 2 | 2006 | 177 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 300 | 0.120 |
Why?
|
| Cell Line, Transformed | 1 | 2014 | 154 | 0.120 |
Why?
|
| NF-KappaB Inhibitor alpha | 2 | 2004 | 41 | 0.120 |
Why?
|
| RING Finger Domains | 1 | 2014 | 4 | 0.120 |
Why?
|
| I-kappa B Proteins | 2 | 2004 | 53 | 0.120 |
Why?
|
| Molecular Weight | 2 | 2005 | 332 | 0.120 |
Why?
|
| Nuclear Export Signals | 1 | 2013 | 1 | 0.120 |
Why?
|
| Antigens, Differentiation | 2 | 2004 | 141 | 0.120 |
Why?
|
| AT Rich Sequence | 1 | 2013 | 7 | 0.120 |
Why?
|
| Microscopy, Electron | 2 | 2006 | 504 | 0.120 |
Why?
|
| Protein Stability | 1 | 2014 | 99 | 0.120 |
Why?
|
| Codon | 2 | 2005 | 124 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2015 | 227 | 0.120 |
Why?
|
| Peptides | 2 | 2007 | 639 | 0.120 |
Why?
|
| Proteolysis | 1 | 2014 | 100 | 0.120 |
Why?
|
| Cell Extracts | 1 | 2013 | 15 | 0.110 |
Why?
|
| Cell Fractionation | 2 | 2005 | 71 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 82 | 0.110 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2012 | 3 | 0.110 |
Why?
|
| Hydroxamic Acids | 1 | 2013 | 49 | 0.110 |
Why?
|
| Female | 8 | 2014 | 44566 | 0.110 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 135 | 0.110 |
Why?
|
| Tunica Intima | 2 | 2003 | 59 | 0.110 |
Why?
|
| Chromatography, Liquid | 1 | 2012 | 105 | 0.110 |
Why?
|
| Combined Modality Therapy | 4 | 2011 | 1686 | 0.110 |
Why?
|
| Stress, Psychological | 1 | 2015 | 314 | 0.110 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 103 | 0.110 |
Why?
|
| Mice, Nude | 7 | 2011 | 789 | 0.100 |
Why?
|
| Octamer Transcription Factors | 1 | 2011 | 5 | 0.100 |
Why?
|
| Nerve Growth Factor | 1 | 2011 | 17 | 0.100 |
Why?
|
| Dactinomycin | 1 | 2011 | 36 | 0.100 |
Why?
|
| Heterochromatin | 1 | 2011 | 22 | 0.100 |
Why?
|
| Amino Acid Chloromethyl Ketones | 2 | 2003 | 25 | 0.100 |
Why?
|
| DNA Mutational Analysis | 1 | 2013 | 526 | 0.100 |
Why?
|
| Cornea | 1 | 2011 | 69 | 0.100 |
Why?
|
| Peptide Hydrolases | 2 | 2001 | 100 | 0.100 |
Why?
|
| Two-Hybrid System Techniques | 2 | 2001 | 55 | 0.100 |
Why?
|
| DNA Fragmentation | 2 | 2001 | 63 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2010 | 13 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2002 | 200 | 0.090 |
Why?
|
| Mutation, Missense | 2 | 2008 | 276 | 0.090 |
Why?
|
| Cyclin D2 | 1 | 2009 | 19 | 0.090 |
Why?
|
| Cytoplasmic Structures | 1 | 2009 | 1 | 0.090 |
Why?
|
| Escherichia coli | 1 | 2012 | 598 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1759 | 0.090 |
Why?
|
| Glioblastoma | 3 | 2014 | 255 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2009 | 89 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 1380 | 0.080 |
Why?
|
| Herpesviridae | 1 | 2008 | 14 | 0.080 |
Why?
|
| Interferon Type I | 2 | 2014 | 175 | 0.080 |
Why?
|
| Dichlororibofuranosylbenzimidazole | 1 | 2008 | 4 | 0.080 |
Why?
|
| Butyrates | 1 | 2008 | 42 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 2 | 2006 | 57 | 0.080 |
Why?
|
| Interleukins | 1 | 2009 | 134 | 0.080 |
Why?
|
| Tosylphenylalanyl Chloromethyl Ketone | 1 | 2008 | 1 | 0.080 |
Why?
|
| Nuclear Pore | 1 | 2008 | 11 | 0.080 |
Why?
|
| Receptors, Interferon | 1 | 2008 | 31 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2008 | 28 | 0.080 |
Why?
|
| trans-Golgi Network | 1 | 2007 | 12 | 0.080 |
Why?
|
| RNA, Antisense | 1 | 2007 | 15 | 0.080 |
Why?
|
| Enzyme Induction | 1 | 2007 | 88 | 0.080 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2007 | 66 | 0.080 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2007 | 34 | 0.080 |
Why?
|
| Human papillomavirus 16 | 1 | 2007 | 38 | 0.070 |
Why?
|
| Peptide Mapping | 1 | 2006 | 26 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 2007 | 33 | 0.070 |
Why?
|
| Histamine | 1 | 2007 | 126 | 0.070 |
Why?
|
| Regional Blood Flow | 1 | 2007 | 197 | 0.070 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2006 | 29 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 115 | 0.070 |
Why?
|
| Antibodies | 1 | 2009 | 352 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 69 | 0.070 |
Why?
|
| Butyric Acid | 1 | 2006 | 11 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2704 | 0.070 |
Why?
|
| Half-Life | 1 | 2006 | 96 | 0.070 |
Why?
|
| Biological Transport, Active | 1 | 2006 | 102 | 0.070 |
Why?
|
| Thermodynamics | 1 | 2007 | 309 | 0.070 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2006 | 21 | 0.070 |
Why?
|
| Arteries | 1 | 2007 | 177 | 0.070 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 15 | 0.070 |
Why?
|
| Vaccines, Synthetic | 1 | 2006 | 55 | 0.070 |
Why?
|
| Cattle | 1 | 2006 | 376 | 0.070 |
Why?
|
| DNA Viruses | 1 | 2005 | 16 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2006 | 347 | 0.070 |
Why?
|
| Cyclin T | 1 | 2005 | 1 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Member 14 | 1 | 2005 | 7 | 0.070 |
Why?
|
| Heparitin Sulfate | 1 | 2005 | 27 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2006 | 101 | 0.070 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 125 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-cbl | 1 | 2005 | 36 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2006 | 352 | 0.060 |
Why?
|
| Nucleic Acid Conformation | 1 | 2006 | 332 | 0.060 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2006 | 262 | 0.060 |
Why?
|
| Genes, Immediate-Early | 1 | 2004 | 17 | 0.060 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 990 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2005 | 119 | 0.060 |
Why?
|
| Tubulin | 1 | 2004 | 58 | 0.060 |
Why?
|
| Interleukin-12 | 1 | 2005 | 109 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2004 | 3 | 0.060 |
Why?
|
| Oncolytic Viruses | 3 | 2011 | 23 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2006 | 288 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2007 | 508 | 0.060 |
Why?
|
| Lung | 2 | 2001 | 1170 | 0.060 |
Why?
|
| Veins | 1 | 2005 | 93 | 0.060 |
Why?
|
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2004 | 3 | 0.060 |
Why?
|
| Interferon-Stimulated Gene Factor 3 | 1 | 2004 | 3 | 0.060 |
Why?
|
| STAT2 Transcription Factor | 1 | 2004 | 6 | 0.060 |
Why?
|
| Janus Kinase 1 | 1 | 2004 | 15 | 0.060 |
Why?
|
| Antineoplastic Agents | 2 | 2008 | 2360 | 0.060 |
Why?
|
| RNA Splicing | 2 | 2002 | 142 | 0.060 |
Why?
|
| Genes, fos | 1 | 2004 | 24 | 0.060 |
Why?
|
| Nocodazole | 1 | 2003 | 18 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2004 | 123 | 0.060 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2003 | 18 | 0.060 |
Why?
|
| I-kappa B Kinase | 1 | 2003 | 38 | 0.060 |
Why?
|
| 5' Untranslated Regions | 1 | 2003 | 49 | 0.060 |
Why?
|
| Nectins | 1 | 2003 | 9 | 0.060 |
Why?
|
| Neoplasm Metastasis | 1 | 2007 | 1056 | 0.060 |
Why?
|
| Hemagglutinins, Viral | 1 | 2002 | 38 | 0.060 |
Why?
|
| Defective Viruses | 1 | 2002 | 12 | 0.060 |
Why?
|
| SUMO-1 Protein | 1 | 2002 | 16 | 0.050 |
Why?
|
| Ethylmaleimide | 1 | 2002 | 11 | 0.050 |
Why?
|
| Vaccines, Inactivated | 1 | 2002 | 29 | 0.050 |
Why?
|
| Dimerization | 1 | 2002 | 143 | 0.050 |
Why?
|
| Vaccines, Attenuated | 1 | 2002 | 51 | 0.050 |
Why?
|
| Cations | 1 | 2002 | 30 | 0.050 |
Why?
|
| Interleukin-6 | 2 | 2017 | 257 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2003 | 180 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2003 | 136 | 0.050 |
Why?
|
| Creatine Kinase | 1 | 2002 | 52 | 0.050 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 302 | 0.050 |
Why?
|
| Restriction Mapping | 1 | 2002 | 157 | 0.050 |
Why?
|
| Vaccines, Subunit | 1 | 2002 | 55 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2004 | 427 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2003 | 119 | 0.050 |
Why?
|
| Herpes Simplex Virus Vaccines | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cricetinae | 1 | 2003 | 560 | 0.050 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2002 | 27 | 0.050 |
Why?
|
| Autoradiography | 1 | 2001 | 69 | 0.050 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 152 | 0.050 |
Why?
|
| Cysteine | 1 | 2002 | 135 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 144 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2001 | 25 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2002 | 155 | 0.050 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 48 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 290 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2001 | 20 | 0.050 |
Why?
|
| Recurrence | 2 | 2001 | 1139 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2002 | 151 | 0.050 |
Why?
|
| History, Medieval | 1 | 2001 | 11 | 0.050 |
Why?
|
| History, 18th Century | 1 | 2001 | 23 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2005 | 2243 | 0.050 |
Why?
|
| Purines | 1 | 2001 | 91 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2001 | 99 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2002 | 263 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 297 | 0.050 |
Why?
|
| History, 19th Century | 1 | 2001 | 59 | 0.050 |
Why?
|
| History, Ancient | 1 | 2001 | 74 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2001 | 57 | 0.050 |
Why?
|
| Antigens, Neoplasm | 1 | 2003 | 325 | 0.050 |
Why?
|
| Apoptosis Inducing Factor | 1 | 2000 | 6 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2002 | 210 | 0.050 |
Why?
|
| E2F5 Transcription Factor | 1 | 2000 | 2 | 0.050 |
Why?
|
| E2F4 Transcription Factor | 1 | 2000 | 2 | 0.050 |
Why?
|
| Transcription Factor DP1 | 1 | 2000 | 5 | 0.050 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 2000 | 10 | 0.050 |
Why?
|
| COS Cells | 1 | 2001 | 166 | 0.050 |
Why?
|
| E2F2 Transcription Factor | 1 | 2000 | 4 | 0.050 |
Why?
|
| E2F Transcription Factors | 1 | 2000 | 19 | 0.050 |
Why?
|
| E2F1 Transcription Factor | 1 | 2000 | 13 | 0.050 |
Why?
|
| Swine | 1 | 2002 | 559 | 0.050 |
Why?
|
| Interleukin-4 | 1 | 2001 | 128 | 0.050 |
Why?
|
| S Phase | 1 | 2000 | 63 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2000 | 132 | 0.050 |
Why?
|
| Interleukin-10 | 1 | 2001 | 149 | 0.050 |
Why?
|
| DNA, Single-Stranded | 1 | 2001 | 92 | 0.050 |
Why?
|
| Male | 3 | 2015 | 40995 | 0.050 |
Why?
|
| Coated Vesicles | 1 | 2000 | 4 | 0.050 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2000 | 53 | 0.050 |
Why?
|
| G2 Phase | 1 | 2000 | 34 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2000 | 408 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 646 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 268 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2004 | 502 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2000 | 144 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2000 | 117 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2000 | 272 | 0.040 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2001 | 168 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2000 | 111 | 0.040 |
Why?
|
| China | 1 | 2020 | 228 | 0.040 |
Why?
|
| Mitosis | 1 | 2000 | 153 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 915 | 0.040 |
Why?
|
| Truth Disclosure | 1 | 2020 | 87 | 0.040 |
Why?
|
| Epitopes | 1 | 2000 | 255 | 0.040 |
Why?
|
| Neoplasm Transplantation | 3 | 2007 | 392 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 2020 | 121 | 0.040 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2000 | 81 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 129 | 0.040 |
Why?
|
| Clinical Trials as Topic | 2 | 2001 | 1169 | 0.040 |
Why?
|
| RNA Transport | 1 | 2018 | 11 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2000 | 786 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 77 | 0.040 |
Why?
|
| Health Personnel | 1 | 2020 | 201 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 17 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2011 | 188 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 1960 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2012 | 592 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2020 | 376 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2007 | 458 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 2904 | 0.030 |
Why?
|
| Brain | 2 | 2002 | 2220 | 0.030 |
Why?
|
| DEAD Box Protein 58 | 1 | 2014 | 11 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2007 | 363 | 0.030 |
Why?
|
| Jugular Veins | 2 | 2005 | 69 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2005 | 240 | 0.030 |
Why?
|
| Cytotoxins | 1 | 2009 | 15 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2009 | 86 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 1944 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2009 | 164 | 0.020 |
Why?
|
| Classification | 1 | 2008 | 54 | 0.020 |
Why?
|
| Genes, Essential | 1 | 2007 | 19 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2007 | 30 | 0.020 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2007 | 31 | 0.020 |
Why?
|
| Luciferases | 1 | 2007 | 119 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 468 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2007 | 206 | 0.020 |
Why?
|
| Genes, ras | 1 | 2006 | 96 | 0.020 |
Why?
|
| Transplantation, Isogeneic | 1 | 2005 | 39 | 0.020 |
Why?
|
| Flavonoids | 1 | 2006 | 85 | 0.020 |
Why?
|
| Adenoviridae | 1 | 2006 | 345 | 0.020 |
Why?
|
| Cytokines | 1 | 2009 | 781 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 193 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2005 | 203 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2009 | 1197 | 0.010 |
Why?
|
| Umbilical Arteries | 1 | 2003 | 16 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 680 | 0.010 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2001 | 16 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2001 | 61 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2006 | 589 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2003 | 437 | 0.010 |
Why?
|
| Prognosis | 1 | 2008 | 3681 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 308 | 0.010 |
Why?
|
| Models, Animal | 1 | 2001 | 264 | 0.010 |
Why?
|
| ROC Curve | 1 | 2003 | 752 | 0.010 |
Why?
|
| Pancreatic Neoplasms | 1 | 2005 | 645 | 0.010 |
Why?
|
| Spinal Cord | 1 | 2001 | 248 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2001 | 1059 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2003 | 1991 | 0.010 |
Why?
|